日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Late endocrine-metabolic complications in survivors of young adult and adult-onset cancers: comprehensive evaluation and strategies for management. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical review

年轻成人和成人发病癌症幸存者晚期内分泌代谢并发症：综合评估和管理策略。意大利肿瘤内科学会 (AIOM)、意大利糖尿病医学会 (AMD)、意大利糖尿病学会 (SID)、意大利内分泌学会 (SIE) 和意大利药理学会 (SIF) 的多学科批判性综述

期刊:Journal of Endocrinological Investigation
影响因子:3.5
doi:10.1007/s40618-025-02764-5
Felicetti, Francesco; Mazzilli, Rossella; Gori, Stefania; Gallo, Marco; Cortellini, Alessio; D'Oronzo, Stella; Gristina, Valerio; Argentiero, Antonella; Candido, Riccardo; Del Re, Marzia; Fogli, Stefano; Franchina, Tindara; Giuffrida, Dario; Marino, Giampiero; Monami, Matteo; Montagnani, Monica; Morviducci, Lelio; Natalicchio, Annalisa; Ragni, Alberto; Renzelli, Valerio; Sciacca, Laura; Tuveri, Enzo; Giorgino, Francesco; Verzé, Matteo; Zatelli, Maria Chiara; Arvat, Emanuela; Perrone, Francesco; Stracci, Fabrizio; Aimaretti, Gianluca; Avogaro, Angelo; Buzzetti, Raffaella; Silvestris, Nicola; Faggiano, Antongiulio
肿瘤
AMD
肿瘤免疫
代谢
糖尿病
发表日期：2026
文献求助 收藏

Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study

观察性研究中，采用多种定义评估GLP-1受体激动剂治疗后2型糖尿病缓解的频率、特征和结果

期刊:Lancet Regional Health-Europe
影响因子:13
doi:10.1016/j.lanepe.2025.101499
Fadini, Gian Paolo; Giaccari, Andrea; Broglio, Fabio; Nollino, Laura; Fattor, Bruno; Anichini, Roberto; Meregalli, Giancarla; Avogaro, Angelo; Consoli, Agostino
糖尿病
信号转导
GLP-1
代谢
发表日期：2025
文献求助 收藏

Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods

利用人工智能驱动的方法，对GLP-1RA的心血管获益进行分层分析：基于患者层面心血管结局试验和真实世界数据的多源分析

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-025-02952-w
Morieri, Mario Luca; Longato, Enrico; Sciannameo, Veronica; Donatiello, Emily; Berchialla, Paola; Avogaro, Angelo; Consoli, Agostino; Fadini, Gian Paolo
GLP-1
发表日期：2025
文献求助 收藏

Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study

2型糖尿病诊断后早期体重减轻、糖尿病缓解和长期发展轨迹：一项回顾性研究

期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-025-06402-w
Morieri, Mario Luca; Rigato, Mauro; Frison, Vera; D'Ambrosio, Michele; Sartore, Giovanni; Avogaro, Angelo; Fadini, Gian Paolo
糖尿病
代谢
发表日期：2025
文献求助 收藏

Long-Term Effectiveness of Once-Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real-World Study

每周一次索玛鲁肽治疗既往接受胰岛素治疗的2型糖尿病患者的长期疗效：一项多中心真实世界研究

期刊:Diabetes-Metabolism Research and Reviews
影响因子:6
doi:10.1002/dmrr.70045
Bonora, Benedetta Maria; Giaccari, Andrea; Consoli, Agostino; Broglio, Fabio; Avogaro, Angelo; Fadini, Gian Paolo
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert Group

利用 CGM 整合提升 2 型糖尿病护理：来自意大利专家组的见解

期刊:Diabetes-Metabolism Research and Reviews
影响因子:6
doi:10.1002/dmrr.70059
Irace, Concetta; Avogaro, Angelo; Bertuzzi, Federico; Buzzetti, Raffaella; Candido, Riccardo; Del Prato, Stefano; Di Bartolo, Paolo; Fiorina, Paolo; Giorda, Carlo Bruno; Giorgino, Francesco
糖尿病
代谢
发表日期：2025
文献求助 收藏

Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease

在患有 2 型糖尿病和慢性肾病的患者中，SGLT-2 抑制剂与对照药物相比，在长期保护肾功能方面具有优势

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16569
Fadini, Gian Paolo; Longato, Enrico; Morieri, Mario Luca; Broglio, Fabio; Aimaretti, Gianluca; Russo, Giuseppina T; Anichini, Roberto; Ghiani, Mariangela; Avogaro, Angelo; Solini, Anna
糖尿病
代谢
发表日期：2025
文献求助 收藏

Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data

口服索玛鲁肽与恩格列净治疗2型糖尿病的疗效比较：基于真实世界数据的PIONEER-2试验模拟

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.70151
Fadini, Gian Paolo; Longato, Enrico; Poletto, Sara; Giaccari, Andrea; Ghiani, Mariangela; Strazzabosco, Marco; Trombetta, Maddalena; Penno, Giuseppe; Avogaro, Angelo; Solini, Anna; Consoli, Agostino
糖尿病
代谢
发表日期：2025
文献求助 收藏

Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies

实体瘤和糖尿病患者的疫苗接种：现有证据和建议。由多个科学学会组成的多学科专家组的立场声明

期刊:Journal of Endocrinological Investigation
影响因子:3.5
doi:10.1007/s40618-025-02586-5
Gallo, Marco; Lasagna, Angioletta; Renzelli, Valerio; Morviducci, Lelio; Cortellini, Alessio; Monami, Matteo; Marino, Giampiero; Gori, Stefania; Verzé, Matteo; Ragni, Alberto; Tuveri, Enzo; Sciacca, Laura; D'Oronzo, Stella; Giuffrida, Dario; Natalicchio, Annalisa; Giorgino, Francesco; Marrano, Nicola; Zatelli, Maria Chiara; Montagnani, Monica; Felicetti, Francesco; Mazzilli, Rossella; Fogli, Stefano; Franchina, Tindara; Argentiero, Antonella; Candido, Riccardo; Perrone, Francesco; Aimaretti, Gianluca; Avogaro, Angelo; Silvestris, Nicola; Faggiano, Antongiulio
糖尿病
代谢
发表日期：2025
文献求助 收藏

Preferences, Expectations and Attitudes on Basal Insulin from Patient-Physician-Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study)

从患者、医生和支付方角度对基础胰岛素的偏好、期望和态度：意大利糖尿病协会的多方利益相关者调查（ITA4P 研究）

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-025-01729-4
Fadini, Gian Paolo; Ciardullo, Stefano; Perseghin, Gianluca; Giordano, Carla; Maddaloni, Ernesto; Buzzetti, Raffaella; Ghiani, Mariangela; Avogaro, Angelo
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏